Previous 10 | Next 10 |
Rajiv Malik to Retire as President of Viatris Effective April 1, 2024 PR Newswire PITTSBURGH , Oct. 20 , 2023 /PRNewswire/ -- Viatris Inc . (NASDAQ: VTRS), a global healthcare company, announced today that its President, Rajiv Malik , will be retiring...
2023-10-20 10:00:29 ET Summary VTRS lost its Humira biosimilar through the divestiture of its biosimilar segment to Biocon, with the former similarly losing another growth prospects in Wegovy. These headwinds suggest that VTRS may unfortunately miss the future gravy train for the ...
2023-10-20 03:02:47 ET Summary Viatris faces declining revenues and increasing R&D, mitigated by aggressive divestitures aimed at operational streamlining and debt reduction. High long-term debt is a concern, but disciplined debt management and a pivot into the ophthalmology s...
Viatris Named to 3BL's 100 Best Corporate Citizens of 2023 Ranking PR Newswire PITTSBURGH , Oct. 18, 2023 /PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS), a global healthcare company, today announced it has been named to 3BL's annual 100 Best Corporate Cit...
2023-10-17 20:30:00 ET Summary With the start of the final quarter of 2023, it’s time to take a look back at my previous month of dividend income. Getting close to that $2,000 milestone in a month sure looks amazing. I know, those end of quarter months are always the big pa...
2023-10-17 08:57:00 ET Summary In September, we (my wife and I) received a dividend income total of $4,987.23. So close to $5,000 this month for our family. The Fed paused a rate hike in September, will likely remain in a hold pattern for November, with a modest chance of an incre...
2023-10-13 09:15:00 ET On Oct. 1, Viatris (NASDAQ: VTRS) made an announcement that's sure to shake up its fortunes. It's divesting nearly all of its over-the-counter (OTC) medicines, its entire women's healthcare segment, and its active pharmaceutical ingredients (API) manufacturing...
Viatris to Release Third Quarter 2023 Financial Results on November 7, 2023 PR Newswire PITTSBURGH , Oct. 10, 2023 /PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS) plans to release its third quarter 2023 financial results on Tuesday, November 7 after the ...
2023-10-08 09:45:00 ET With bond yields rising and interest rates expected to remain elevated for several more quarters, value stocks are starting to look mighty enticing. Value stocks are equities that trade at low earnings multiples, price-to-sales multiples, or book values relative to th...
2023-10-08 08:15:00 ET For income-seeking investors, the only thing better than a solid dividend stock is a beaten-down one whose shares can be bought on the dip. And while the market has largely recovered this year, some dividend-paying corporations missed the memo and have substantially l...
News, Short Squeeze, Breakout and More Instantly...
NORTHAMPTON, MA / ACCESSWIRE / July 23, 2024 / No country can make every medicine people need, and no medicine is made in every country. If a country or region relies on supply only from within their region and they experience a crisis, there is a risk people won't get the medicines they need, w...
NORTHAMPTON, MA / ACCESSWIRE / July 18, 2024 / Viatris is a global healthcare company focused on bringing high-quality medicines to patients through a hybrid approach that bridges the traditional divide between generics and brands, combining the best of both, to more holistically address healthc...
2024-07-15 10:32:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...